Home > Balance Sheet > CIPLA

CIPLA
Total Non-Current Liabilities

    Back to Balance Sheet
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹-31 Cr₹82 Cr₹184 Cr₹622 Cr₹1,660 Cr

What is the latest Total Non-Current Liabilities ratio of CIPLA ?

The latest Total Non-Current Liabilities ratio of CIPLA is ₹-31 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹-31 Cr
Mar2024₹82 Cr
Mar2023₹184 Cr
Mar2022₹622 Cr
Mar2021₹1,660 Cr

How is Total Non-Current Liabilities of CIPLA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹-31 Cr
Negative
Mar2024 ₹82 Cr
-55.36
Mar2023 ₹184 Cr
-70.48
Mar2022 ₹622 Cr
-62.55
Mar2021 ₹1,660 Cr -

Compare Total Non-Current Liabilities of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹121,178.1 Cr 1% -0.9% -1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,782.0 Cr -1% -4.9% -7.6% Stock Analytics
DIVIS LABORATORIES ₹168,376.0 Cr -1.6% -0.4% 9.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹130,225.0 Cr 0.2% 2.8% 12.2% Stock Analytics
DR REDDYS LABORATORIES ₹104,629.0 Cr 0.4% 0.9% -8.9% Stock Analytics
MANKIND PHARMA ₹89,293.9 Cr 0.1% -1.5% -25.1% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

1%

-0.9%

-1%

SENSEX

-0.3%

-0.5%

8.3%


You may also like the below Video Courses